Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PFMT > SEC Filings for PFMT > Form 8-K on 5-Feb-2014All Recent SEC Filings




Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 3, 2014, the Board of Directors of Perfomant Financial Corporation (the "Company") approved, effective as of February 4, 2014, the election of Mr. Bradley M. Fluegel as a Class III director to fill the newly created vacancy due to the resignation of Jeffrey S. Stein, also effective as of February 4, 2014. Mr. Fluegel is currently the Senior Vice President-Chief Strategy Officer for Walgreen Co. (NYSE: WAG). The Board of Directors has determined that Mr. Fluegel is "independent" for purposes of the listing standards of The Nasdaq Stock Market LLC ("Nasdaq Rules"). Mr. Fluegel will also serve on the compensation committee and on the nominating and governance committee.

Consistent with the compensation currently provided to the members of the Company's Board of Directors, Mr. Fluegel will receive an annual retainer of $30,000 and additional annual retainers of $5,000 for service on our nominating and governance committee and $6,000 for service on our compensation committee, in each case prorated for partial service this year. He will also receive restricted stock units valued at $75,000 annually that will vest over four years and such restricted stock units will be granted following the 2014 Annual Meeting of Stockholders. The Company and Mr. Fluegel will also enter into the Company's customary form of indemnification agreement.

In addition, on February 4, 2014, the effective date of Mr. Fluegel's appointment to the Board of Directors, Mr. Fluegel was granted restricted stock units under the Company's 2012 Stock Incentive Plan with respect to 13,495 shares of the Company's common stock (equal to $100,000 divided by the fair market value of one share of the Company's common stock on February 4, 2014). The restricted stock units shall vest in four equal installments on each annual anniversary of the date of grant in 2015, 2016, 2017 and 2018.

There was no arrangement or understanding between Mr. Fluegel and any other person pursuant to which Mr. Fluegel was elected as a director. There are no transactions or relationships between the Company and Mr. Fluegel that are reportable under Item 404(a) of Regulation S-K.

Mr. Stein's resignation is part of the Company's compliance with Nasdaq Rules
(i) that the Company's Board of Directors consists of a majority of independent directors and (ii) that the compensation committee, audit committee and nominating and governance committee consist solely of independent directors, each such requirement to be met within one year of the Company ceasing to be a "controlled company," pursuant to Nasdaq Rules. Mr. Stein's resignation is not a result of any disagreement with the Company on any matter relating to the Company's operations or practices. Prior to his resignation, Mr. Stein was a member of the Company's compensation committee.

  Add PFMT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PFMT - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.